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Ability of Biochemical Parameters to Distinguish between Bile
and obesity, metabolic syndrome, diabetes mellitus, dyslipidemia, thiazide diuretics, female sex hormones, reduced physical activity, TPN, Crohn's disease, cirrhosis, rapid weight loss respectively (Premkumar et al., 2012) . The rate of occurrence of gallstones becomes 4-10 times in older individuals particularly after the age of 40. The stone types also alter with age, to begin with predominantly of cholesterol but in late life tending to be black pigment stones (Schirmer et al., 2005) .
Various metabolic changes such as hepatic insulin resistance, low HDL, high cholesterol level, hypertriglyceridemia have been implicated in gall stone formation and bile duct cancer (Xu et al., 2011) . Although, clinical history and blood variables such as total bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), albumin, haemoglobin (Hb), erythrocyte sedimentation rate (ESR), total leukocyte count (TLC), urea and sugar are routinely measured for every gallstone patient, (Habib et al., 2009) , the variation of these parameters to make a distinction between bile duct cancer and gall bladder stone has not been appraised. Thus, the objective of present study was designed to assess the alteration of biochemical parameters in bile duct cancer and gall stone disease.
Materials and Methods
It was a hospital based case control study carried out in the Department of Biochemistry of Manipal Teaching Hospital, Pokhara, Nepal between 1 st January 2010 and 31 st December 2012. The variables collected were age, gender, serum total cholesterol, total bilirubin, AST and ALT serum alkaline phosphatase, albumin and hemoglobin. Approval for the study was obtained from the institutional research ethical committee. Estimation of total cholesterol was done by CHOD-PAP method respectively (Trinder, 1969) . The total bilirubin was estimated by Jendrassik/ Grof method (Garber, 1981) . The transaminases (AST and ALT) were estimated by liquid UV test (Henley et al., 1955) . Estimation of serum alkaline phosphatases was done by standard enzymatic method (German, 1972) . The albumin was measured by BCG method (Doumas et al., 1971) . Estimation of hemoglobin was done by a portable hemoglobinometer (Gong et al., 1999) . All these laboratory parameters were analyzed using Human reagent kits and with the help of semi autoanalyser (Human, Germany). Analysis was done using descriptive statistics and testing of hypothesis. The data was analyzed using 
Results
Out of 90 cases selected, 30 were of cancer, 30 were of stone and rest were controls. Table 1 illustrates that mean age of cases and controls were 53.3±21.24 yrs. There was total 60 cases and out of that 30 were of cancer origin and rest were of stone. Number of females were more in comparison to males in cases of bile duct cancer and gall stone. Out of 30 cases of cancer origin, 16 were of bile duct cancer, 2 were of intrahepatic cancer, 8 were of perihilar cancer, 2 were of extrahepatic cancer and 2 were of gall bladder cancer. Out of 30 cases of stone, 20 were of gall bladder stone, 7 were of common bile duct stone, and 3 were of intrahepatic duct stone. 
Discussion
Cholelithiasis is a major health problem world wide, particularly in adult population. There is a considerable geographical and regional variation in its prevalence. Intra operative ultrasonography is not widely available in our health care system especially in Nepal for accurate differentiating between bile duct cancer and stones. Furthermore, the long list of investigations makes the diagnostic pathway complex and expensive in developing countries. The components of LFT's appears to be a easily available, cheap and better indicator for differentiating between bile duct cancer and gall stones. In our present DOI:http://dx.doi.org/10.7314/APJCP.2013.14.2.817 Biochemical Distinction between Bile Duct Cancer and Gall Bladder Stones in Pokhara Valley study, number of females were more in cases of bile duct cancer and gall stone as mutagenic toxins secreted reside longer in the gallbladder due to stasis from impaired contractility associated with the female hormone, progesterone. The cholesterol levels were more in cases of bile duct cancer 192. 45±21.50 mg/dl (182.92, 203.06) and gall stone 168.65±16.05 mg/dl (160.85, 176.54 ) when compared to controls 138.1±12.7 mg/dl (131.8, 144.4) (p:0.0001*). Our results concurred with Andreotti (Andreotti et al., 2008) . Hepatic insulin resistance which is common metabolic dearrangement in both the gall stone formation and bile duct cancer may act by enhancing hepatic cholesterol secretion, depressing bile salt synthesis and/or impairing gallbladder motility (Biddinger et al., 2008) . The serum total bilirubin showed a marked difference for bile duct cancer (7.6±3.2 mg/dl) when compared to gall stone formation (2.5±0.8 mg/dl) as there was severe obstruction in cancer cases (p: 0.0001*). The study done by park also showed similar results (Park et al., 2006) . In both cancer and stone cases, mildly raised AST and ALT suggested the very less injury to hepatocytes. The serum alkaline phosphatase was markedly raised in cancer cases 251.5± 20.1IU/L (241.8, 261.1) when compared to stone cases 173.2±12.6IU/L (169.5, 176.9) and controls 84.5±13.5 IU/L (78.1, 90.1) due to more severe injury to bile duct epithelial cells in cancer cases (p: 0.0001*) (Bhudhisawasdi et al., 2004) . Furthermore, it was more raised in females owing to increased bone turn over or simultaneous formation of osteoid. Reduced hepatic function in cancer cases 3.1±0.6g/dl (2.8, 3.4) lead to decreased synthesis of albumin when compared to stone 4.1±0.8 g/dl (3.7, 4.5) and controls 4.8±0.6 g/ dl (4.5, 5.1) (p: 0.0001*) (Zare et al., 2011) . Thus, this study found statistically significance positive correlation of biochemical parameters to make a distinction between bile duct cancer and gall bladder stones.
In conclusion, LFT's analysis in pre-operative assessment was a good predictive marker in setting apart bile duct cancer and gall bladder stone.
